DX
Daxor Corporation
DXR · NASDAQ
$11.18 -4.49% (-$0.53)
1M +14.43%
Market Cap $67.9M
P/E Ratio 7.40x
Div. Yield -
ROE 21.69%
Bulios Fair Price
$8.05
28.0% downside
Trenutna cena
$11.18
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DXR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
86 /100
Cheap P/E 7.40x
EV/EBITDA 7.40x
P/S 134.87x
Growth
100 /100
Growing EPS growth 45.29%
Book val. growth 16.57%
Rev. growth N/A
Profitability
65 /100
Moderate Gross margin 37.49%
Net margin 1,821.48%
Op. margin 1,824.65%
Quality
85 /100
Excellent ROIC 19.96%
ROE 21.69%
ROA 19.93%
Debt
100 /100
Low Debt/Equity 0.00x
Int. coverage 575.44x
Net debt/EBITDA 0.01x
Stability
16 /100
Unstable Beta 0.26x
Rev. volatility 5,758.58%
EPS volatility 914.46%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DXR
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael Richard Feldschuh
Employees
37
Headquarters
Oak Ridge
Prihajajoči dogodki
10 MAR.
Earnings
Upcoming earnings report